Elon Musk's Neuralink faces potential delays in brain implant rollouts due to recent FDA layoffs, which some fear could create conflicts of interest. Approximately 20 FDA employees from the neurological devices office were let go, impacting the review of Neuralink and competitors, although the agency claims they were not targeted. The layoffs were conducted by the Department of Government Efficiency and raised alarms over oversight, especially amid tight deadlines for upcoming human trials. Neuralink aims to expand patient trials quickly but the recent workforce reductions might hinder progress.
Musk's critics warn of conflict of interest as FDA cuts affect the monitoring of his Neuralink brain implants, potentially slowing the company's rollout.
Despite open layoffs at the FDA, sources claim no targeting of employees overseeing Neuralink, raising concerns about oversight amid significant budget cuts.
Collection
[
|
...
]